pISSN 1226-6051
eISSN 2508-786X

Table. 2.

Table. 2.

Bone assessment

Prior to transplant N (%) Post to transplant N (%)
Bone mineral density
Normal* 27/57 (47.4) 27/57 (47.4)
Osteopenia 18/57 (31.6) 22/57 (38.6)
Osteoporosis 12/57 (21.1) 8/57 (14.0)

Fracture site
Osteopenia patient
Lumbar 1/57 (1.8) -
Femur - 1/57 (1.8)
Osteoporosis patient
Lumbar 1/57 (1.8) 1/57 (1.8)
Femur 1/57 (1.8) 1/57 (1.8)
Thoracic - 1/57 (1.8)

During the study period
mean±SD

DXA (dual energy X-ray absorptiometry)
Total number of follow up DXA (visit) 3.0±1.0
Time interval; follow up every DXA (month) 27.5±19.2
Time interval; transplant to first DXA after liver transplant (month) 29.7±30.0

Lumbar bone density change (%) 1.2±1.0
Femur neck bone density change (%) -7.2±7.3

Major osteoporotic fracture risk (%) 6.7±5.7
Hip fracture risk (%) 2.1±3.8

*Normal: T-score≥-1.0

Osteopenia: -1>T-score>-2.5

Osteoporosis: T-score≤-2.5

Korean J Clin Pharm 2020;30:51-8 https://doi.org/10.24304/kjcp.2020.30.1.51
© 2020 Korean J Clin Pharm